AnandRathi

Ipca Laboratories Financial Results

BSE Code: 524494NSE Symbol:IPCALABISIN: INE571A01038

1585.8 42.2(2.73)

Open (Rs) 1551

Close (Rs) 1543.6

High (Rs) 1609.1

Low (Rs) 1542.5

Face Value1

Market Capital (Cr.)40232.38

Daily Volume262446

Life Time High1755.9

Life Time Low2.75

52 Week High1678.3

52 Week Low1251.6

Results

Consolidated
IN CRMAR 2026MAR 2025MAR 2024MAR 2023MAR 2022MAR 2021
Net Sales9,646.338,939.597,705.046,244.325,829.795,419.99
Total Expenditure7,667.777,213.456,383.885,317.554,520.533,875.64
PBIDT (Excl OI)1,978.561,726.141,321.16926.771,309.261,544.35
Other Income174.4592.80124.77125.6266.5762.84
Operating Profit2,153.011,818.941,445.931,052.391,375.831,607.19
Interest75.9484.93138.2745.547.699.04
Exceptional Items-86.43-205.05-107.750.000.000.00
PBDT1,990.641,528.961,199.911,006.851,368.141,598.15
Depreciation418.12397.82357.24261.56232.42209.17
Profit Before Tax1,572.521,131.14842.67745.291,135.721,388.98
Tax381.15343.61313.46253.36224.77240.14
Provisions and contingencies0.000.000.000.000.000.00
Profit After Tax1,191.37787.53529.21491.93910.951,148.84
Extraordinary Items0.000.000.000.000.000.00
Prior Period Expenses0.000.000.000.000.000.00
Other Adjustments0.000.000.000.000.000.00
Net Profit1,191.37787.53529.21491.93910.951,148.84
Equity Capital25.3725.3725.3725.3725.3725.37
Face Value (IN RS)1.001.001.001.001.002.00
Reserves8,038.446,923.086,306.825,816.655,466.604,676.28
Basic Eps After Extraordinary Items44.9829.0821.5718.5834.8589.87
Basic Eps Before Extraordinary Items44.9829.0821.5718.5834.8544.94
No of Public Share Holdings0.000.000.000.000.000.00
% of Public Share Holdings0.000.000.000.000.000.00
PBIDTM% (Excl OI)20.5119.3117.1514.8422.4628.49
PBIDTM%22.3220.3518.7716.8523.6029.65
PBDTM%20.6417.1015.5716.1223.4729.49
PBTM%16.3012.6510.9411.9419.4825.63
PATM%12.358.816.877.8815.6321.20

FAQs

What are the Net Sales of Ipca Laboratories in the financial year 2026?

For FY 2026, Ipca Laboratories recorded Net Sales of 9646.33 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

What is the Operating Profit of Ipca Laboratories in 2026?

The Operating Profit of Ipca Laboratories for FY 2026 is 2153.01 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

What is the Profit Before Tax (PBT) of Ipca Laboratories in 2026?

In FY 2026, Ipca Laboratories posted a Profit Before Tax of 1572.52 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

What is the Net Profit of Ipca Laboratories for 2026?

Ipca Laboratories recorded a Net Profit of 1191.37 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

What is the Face Value of Ipca Laboratories?

The Face Value of Ipca Laboratories shares is 1.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

What is the PAT Margin (PATM%) of Ipca Laboratories in 2026?

In FY 2026, the PAT Margin of Ipca Laboratories is 12.35 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

How to open a Demat Account with Anand Rathi to invest in Ipca Laboratories?

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Ipca Laboratories using our TradeMobi App or Web Trading Platform.